AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Medistim

Earnings Release • Feb 26, 2021

3662_rns_2021-02-26_fee6c3d5-c6de-428e-b5cb-9de0a6027c06.html

Earnings Release

Open in Viewer

Opens in native device viewer

4th quarter report and preliminary financials for 2020 for Medistim ASA

Sales for the quarter ended at MNOK 94.2 (MNOK 95.7), a decrease of 1.6%. Sales for 2020 ended at MNOK 363.1 (MNOK 363.7). Operating result (EBIT) for the quarter ended at MNOK 22.1 (MNOK 19.7) a 12.1% increase. Operating result the year 2020 ended at MNOK 95.5 (MNOK 89.8), a 6.4% increase. This is the best operating result for a year ever. Cashflow from operations was a solid MNOK 74.3. Cash by the end of the year was MNOK 71.9 after a dividend of MNOK 50.1 in November. Medistim has entered a Distribution agreement with LivaNova for India. The Board will suggest to the General Meeting a dividend of NOK 3.00 per share.